Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation

BACKGROUND: Cellular therapy after organ transplantation is emerging as an intriguing strategy to achieve dose reduction of classical immunosuppressive pharmacotherapy. Here, we introduce a new scoring system to assess treatment-emergent adverse events (TEAEs) of adherent stem cell therapies in the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dillmann, Johannes, Popp, Felix C, Fillenberg, Barbara, Zeman, Florian, Eggenhofer, Elke, Farkas, Stefan, Scherer, Marcus N, Koller, Michael, Geissler, Edward K, Deans, Robert, Ladenheim, Deborah, Loss, Martin, Schlitt, Hans J, Dahlke, Marc H
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2012
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3543274/
https://ncbi.nlm.nih.gov/pubmed/23151227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-13-211
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares